On May 17, 2019, Wuhan General Group (“Wuhan”) announced signing a Letter of Intent (“LOI”) with Biodelta Nutraceuticals, Ltd. This announcement follows Wuhan’s April 5, 2019 announcement that its wholly-owned …
In late April of 2019, both the United States Patent and Trademark Office (“USPTO”) and the World Intellectual Property Office (“WIPO”) published Compass Pathways’s Patent Applications directed to psilocybin technology. …
[Updated May 1st, 2019] Are magic mushrooms (or psilocybin) going to be the next big investment opportunity after cannabis? Many investors think yes. But it’s hard to invest in psychedelics …
The scientific community universally agrees that psilocybin and/or magic mushrooms have enormous potential for treating some of the world’s biggest health problems. Furthermore, scientists agree that psychedelics (like magic mushrooms, …
Recent developments in science and policy reform suggest that “magic mushrooms” and psilocybin technology will evolve into a psilocybin industry. Investments by several early movers illustrate that a psilocybin industry …
The molecule Psilacetin (aka 4-AcO-DMT or O-Acetylpsilocin) is a synthetic psilocybin derivative. Like psilocybin, psilacetin serves as a prodrug of psilocin, which is the primary active molecule responsible for the …
Best-selling author, entrepreneur, and angel investor Tim Ferriss praises the benefits of psychedelics. Mr. Ferriss financially supports psychedelic research and he methodically uses psychedelics for treating depression and enhancing cognition. …
No Magic Mushroom Monopoly Relax. No one is trying to monopolize magic mushrooms. COMPASS Pathways is not trying to monopolize magic mushrooms. Renewed interest in psychedelic medicine (e.g., psilocybin) is not part …
Three Points to Remember when Writing about Psilocybin or “Magic Mushrooms” For good reason, the mainstream media have taken an increased interest in psychedelic sciences. Given that many journalists are …
Cost of Psilocybin How much should psilocybin cost — per gram and per dose? With the renewed interest in psilocybin, some have questioned whether commercial involvement will impede access to …
